# Immersivetouch

- Location (FDA's records): Chicago, IL
- FDA decisions: 4 (2014–2023): 4 510(k) clearances
- Names in FDA's records: Immersivetouch (3); Immersivetouch, Inc. (1)
- Product codes: LLZ (3), DZJ (1)
- 510(k) review time since 2016: median 259 days, against 157 for FDA's reviews in the same codes and years (0 of 3 faster)
- Predicates its devices cite: 5 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Medivis, Inc.: 1 (https://510kreport.com/company/medivis)
- Surgical Theater, LLC: 1 (https://510kreport.com/company/surgical-theater)
- Simbionix, Ltd.: 1 (https://510kreport.com/company/simbionix)
- Materialise NV: 1 (https://510kreport.com/company/materialise)
- Medical Modeling, Inc.: 1 (https://510kreport.com/company/medical-modeling)

## Firms that cite its devices most
- Clarus Viewer Corporation: 1 (https://510kreport.com/company/clarus-viewer)
- Skia, Inc.: 1 (https://510kreport.com/company/skia)

## Its most-cited devices
- K230249: Ikshana (2023), cited by 1
- K210726: ImmersiveTouch (2021), cited by 1

## Recent decisions
- K230249: Ikshana (Oct 16, 2023)
- K210726: ImmersiveTouch (Sep 29, 2021)
- K181813: ImmersiveView Surgical Plan (IVSP®) (Jun 9, 2020)
- K140860: ImmersiveTouch3 and MicrovisTouch (Dec 16, 2014)

Source page: https://510kreport.com/company/immersivetouch